Fresenius Kabi — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Fresenius Kabi appears in 13 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials13

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

13 shown

bIosimilar of aDalimumab, an European evAluationNCT05190484 · lead sponsor · 2022-04-30

A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic ResponseNCT05051943 · lead sponsor · 2020-09-29

Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2NCT03666546 · lead sponsor · 2018-11-26

Efficacy Study of Long-term Parenteral Nutrition With SmofKabiven® E in Lung Cancer Patients Under Anticancer TherapyNCT03355079 · lead sponsor · 2018-02-28

Efficacy and Safety Study of a Low-carbohydrate Tube Feed in Critically Ill Patients Under Insulin TherapyNCT02503527 · lead sponsor · 2015-08-01

Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic PatientsNCT01241695 · lead sponsor · 2010-11-01

Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer PatientsNCT00851448 · lead sponsor · 2009-10-01

Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease PatientsNCT00852020 · lead sponsor · 2009-04-01

Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)NCT00363987 · lead sponsor · 2006-05-01

Pre-operative Short-term Administration of a Formula Diet Containing a Non-milk-derived Protein Source for Prevention of Acute Kidney Injury After Cardiac SurgeryNCT03715868 · collaborator · 2019-01-15

Supplemented Low Protein Diet and Progression of CKDNCT03818568 · collaborator · 2017-11-01

Brief Title:Effect of a Preoperative Calorie Restriction on Renal Function After Cardiac SurgeryNCT01534364 · collaborator · 2012-01-01

Colloids in Severe TraumaNCT00890383 · collaborator · 2009-05-01

Drugs studied in this sponsor's trials

1 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Fresenius Kabi as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

glucose RxCUI 4850 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor9

collaborator4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.